---
title: "Ethosuximide - Absence seizure - 2"
sidebar: mydoc_sidebar
permalink: db00593-mesh-d004832-2.html
toc: false 
---


Path ID: `DB00593_MESH_D004832_2`
{% include image.html url="images/db00593-mesh-d004832-2.png" file="db00593-mesh-d004832-2.png" alt="db00593-mesh-d004832-2" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D005013 | Ethosuximide | Drug |
| GO:0005228 | Intracellular sodium activated potassium channel activity | MolecularActivity |
| GO:0015269 | Calcium-activated potassium channel activity | MolecularActivity |
| MESH:D009569 | Nitric oxide | ChemicalSubstance |
| GO:0042747 | Paradoxical sleep | BiologicalProcess |
| MESH:D004832 | Absence seizure | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Ethosuximide | DECREASES ACTIVITY OF | Intracellular Sodium Activated Potassium Channel Activity |
| Intracellular Sodium Activated Potassium Channel Activity | INCREASES TRANSPORT OF | Nitric Oxide |
| Ethosuximide | DECREASES ACTIVITY OF | Calcium-Activated Potassium Channel Activity |
| Calcium-Activated Potassium Channel Activity | INCREASES TRANSPORT OF | Nitric Oxide |
| Nitric Oxide | POSITIVELY REGULATES | Paradoxical Sleep |
| Paradoxical Sleep | PREVENTS | Absence Seizure |
|---------|-----------|---------|

Reference: [https://go.drugbank.com/drugs/DB00593#mechanism-of-action](https://go.drugbank.com/drugs/DB00593#mechanism-of-action){:target="_blank"}